Julie Gottlieb Fisher, MD
Julie Gottlieb Fisher, MD, medical oncologist at Atrium Health’s Levine Cancer Institute, spoke with Healio about managing patients with metastatic breast cancer.
In this video, Fisher discusses:
- her experience with recently-approved treatments, including PARP inhibitors and CDK4/6 inhibitors;
- indications of metastatic disease that physicians may overlook;
- concerns with long-term, routine surveillance imaging, including unnecessary costs, patient exposure and the risk for false-positive results;
- a study that showed cell-free DNA predicted outcomes of patients with metastatic triple-negative breast cancer; and
- advice for physicians providing palliative care.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.